However, our results revealed a significant decrease in SMO and GLI‐1 protein levels in tumor tissues, suggesting that Rab23 plays a negative regulatory role in the SHH signaling pathway and can suppress tumor growth in HCC. Here, RAB23 is linked to hepatocellular carcinoma.